Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis
ConclusionCurrent data encourages a broader application of AHSCT for treating patients with MS while still considering proper patient selection and transplant methods. In addition, with increasing knowledge and expertise in the field of stem-cell therapy, AHSCT has become a safer treatment approach for MS.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Autoimmune Disease | Brain | Clinical Trials | Disability | Hematology | Multiple Sclerosis | Neurology | Neuroscience | Science | Stem Cell Therapy | Stem Cells | Study | Transplants